Advertisement

Cell Biochemistry and Biophysics

, Volume 72, Issue 1, pp 259–263 | Cite as

Therapeutic Value of Blood Purification and Prognostic Utilities of Early Serum Procalcitonin, C Reactive Protein, and Brain Natriuretic Peptide Levels in Severely Burned Patients with Sepsis

  • Hongxu Zu
  • Qinghua Li
  • Peixin Huang
  • Xiaorong WangEmail author
Original Paper

Abstract

The objective of this study was to evaluate therapeutic effectiveness of blood purification (BP) in severely burned patients with sepsis and to assess the prognostic utilities of early serum levels of procalcitonin (PCT), C reactive protein (CRP), brain natriuretic peptide (BNP). One hundred and ninety-five burn sepsis patients admitted in our hospital during May, 2008–May, 2014 were selected for the study and randomly divided into BP treatment (n = 98) and the control groups (n = 97). All of these patients received conventional therapy, while the BP group underwent additional BP treatment. Therapeutic effectiveness and survival rates of the two groups were compared 28 days after the treatment. The BP group was further divided into survivor and mortality groups, and the early serum levels of PCT, CRP, and BNP were compared retrospectively to analyze their relationship with prognosis. Acute physiology and chronic health evaluation and sequential organ failure assessment scores in the two groups were not significantly different before the treatment (p > 0.05). However, after the treatment, mortality in BP group (19.39 %) was significantly lower (p < 0.05) than that of the controls (27.84 %). Serum levels of PCT and CRP in the survivor and mortality groups were not significantly different (p > 0.05), whereas the serum BNP was significantly lower in the patients who survived than those who died (p < 0.05). The receiver-operating characteristic curve analysis further showed that predictive value of PCT and CRP for the burn sepsis prognosis was low (p > 0.05), however, that of the BNP was good (p < 0.05). The results obtained in this study indicate that BP treatment at an early stage can significantly improve the prognosis of burn sepsis. Furthermore, BNP, an important mediator involved in myocardial infarction and heart failure was found to be positively related with the severity of sepsis suggesting its reliable utility as prognostic indicator of sepsis. Thus, serum BNP monitored during the treatment may assist in adjusting the therapeutic strategies.

Keywords

Procalcitonin C reactive protein Brain natriuretic peptide Blood purification Burn sepsis prognosis 

References

  1. 1.
    Luo, H., Li, X., & Cao, W. (2014). Advances in the research of effects of changes in immune function, coagulation function, and metabolism due to burn sepsis on wound healing. Zhonghua Shao Shang Za Zhi, 30(2), 137–140.PubMedGoogle Scholar
  2. 2.
    Mattick, J. S., et al. (2013). Impact of burn priming on immune and metabolic functions of whole Liver in a rat cecal ligation and puncture model. The International Journal of Burns and Trauma, 3(1), 55–65.Google Scholar
  3. 3.
    Lucas, K., et al. (2012). Retinal laser burn-induced neuropathy leads to substance P-dependent loss of ocular immune privilege. The Journal of Immunology, 189(3), 1237–1242.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Oncul, O., et al. (2014). Nosocomial infection characteristics in a burn intensive care unit: Nalysis of an eleven-year active surveillance. Burns, 40(5), 835–841.PubMedCrossRefGoogle Scholar
  5. 5.
    Barajas-Nava, L. A., et al. (2013). Antibiotic prophylaxis for preventing burn wound infection. Cochrane Database of Systematic Reviews, 6, CD008738.PubMedGoogle Scholar
  6. 6.
    Schultz, L., et al. (2013). Identification of predictors of early infection in acute burn patients. Burns, 39(7), 1355–1366.PubMedCrossRefGoogle Scholar
  7. 7.
    Basu, A. (2011). Invasive burn wound infection. Indian Journal of Surgery, 73(4), 319–320.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Nishimura, H., et al. (2014). Effects of blood purification therapy on a patient with ifosfamide-induced neurotoxicity and acute kidney injury. The Journal of Artificial Organs, 17(1), 110–113.CrossRefGoogle Scholar
  9. 9.
    Zhou, J. X., et al. (2013). Role of acute kidney injury staging by KDIGO criteria in choosing the opportune time of continuous blood purification. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 25(7), 420–423.PubMedGoogle Scholar
  10. 10.
    Yue, R. Z., et al. (2012). Continuous blood purification therapy on 16 patients with diabetic ketoacidosis and acute kidney injury. Sichuan Da Xue Xue Bao Yi Xue Ban, 43(3), 434–437.PubMedGoogle Scholar
  11. 11.
    Tang, W. X., et al. (2012). Combined blood purification for treating acute fatty liver of pregnancy complicated by acute kidney injury: a case series. The Journal of Artificial Organs, 15(2), 176–184.CrossRefGoogle Scholar
  12. 12.
    Hu, G., et al. (2014). Effects of blood purification in the treatment of patients with burn sepsis. Zhonghua Shao Shang Za Zhi, 30(3), 213–218.PubMedGoogle Scholar
  13. 13.
    Peng, Z. Y., et al. (2013). Development of venovenous extracorporeal blood purification circuits in rodents for sepsis. Journal of Surgical Research, 185(2), 790–796.PubMedCrossRefGoogle Scholar
  14. 14.
    Peng, Z. Y., et al. (2012). Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney International, 81(4), 363–369.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Han, S. S., et al. (2011). Effect of continuous blood purification on endothelial cell function in patients with severe sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 23(2), 81–84.PubMedGoogle Scholar
  16. 16.
    Su, L., et al. (2013). Diagnostic value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction. Mediators of Inflammation, 2013, 969875.PubMedCentralPubMedGoogle Scholar
  17. 17.
    Hur, M., et al. (2014). Diagnostic and prognostic utilities of multimarkers approach using procalcitonin, B-type natriuretic peptide, and neutrophil gelatinase-associated lipocalin in critically ill patients with suspected sepsis. BMC Infectious Diseases, 14, 224.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Sankar, V., & Webster, N. R. (2013). Clinical application of sepsis biomarkers. The Journal of Anesthesia, 27(2), 269–283.CrossRefGoogle Scholar
  19. 19.
    Zu, H., Li, Q., & Huang, P. (2014). Expression of treg subsets on intestinal T cell immunity and endotoxin translocation in porcine sepsis after severe burns. Cell Biochemistry and Biophysics, 70, 1699–1704.PubMedCrossRefGoogle Scholar
  20. 20.
    Zhou, P., et al. (2014). Knockdown of Burton’s tyrosine kinase confers potent protection against sepsis-induced acute lung injury. Cell Biochemistry and Biophysics, 70(2), 1265–1275.PubMedCrossRefGoogle Scholar
  21. 21.
    Serebruany, V.L., et al. (2013) Fatal sepsis and systemic inflammatory response syndrome after off-label prasugrel: A case report. American Journal Of Therapeutics.Google Scholar
  22. 22.
    Shozushima, T., et al. (2011). Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. The Journal of Infection and Chemotherapy, 17(6), 764–769.CrossRefGoogle Scholar
  23. 23.
    Haasper, C., et al. (2010). Prognostic value of procalcitonin (PCT) and/or interleukin-6 (IL-6) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome (MODS) or sepsis. Technology and Health Care, 18(2), 89–100.PubMedGoogle Scholar
  24. 24.
    Werdan, K., et al. (2009). Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Canadian Journal of Physiology and Pharmacology, 87(4), 266–274.PubMedCrossRefGoogle Scholar
  25. 25.
    Chai, J. K. (2013). Diagnosis and comprehensive management of sepsis after burn. Zhonghua Shao Shang Za Zhi, 29(2), 105–108.PubMedGoogle Scholar
  26. 26.
    Yizhi, P., et al. (2013). Diagnostic criteria and treatment protocol for post-burn sepsis. Critical Care, 17(1), 406.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Chai, J., Sheng, Z., & Yang, H. (1999). Treatment of invasive burn wound infection with sepsis: a clinical study. Zhonghua Yi Xue Za Zhi, 79(12), 908–910.PubMedGoogle Scholar
  28. 28.
    Li, M. Q., et al. (2014). Efficacy of various combined blood purification techniques for treating patients with non-viral acute liver failure. Cell Biochemistry and Biophysics, 68(3), 571–575.PubMedCrossRefGoogle Scholar
  29. 29.
    Cheng, J., et al. (2013). Comparison of the therapeutic effectiveness of sustained low-efficiency dialysis (SLED) with continuous blood purification (CBP) in critically ill patients. Cell Biochemistry and Biophysics, 67(3), 923–927.PubMedCrossRefGoogle Scholar
  30. 30.
    Rimmele, T., & Kellum, J. A. (2011). Clinical review: Blood purification for sepsis. Critical Care, 15(1), 205.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Yang, J., & Tian, Z. F. (2010). Effect of continuous blood purification on plasma cytokines in children with severe sepsis. Nan Fang Yi Ke Da Xue Xue Bao, 30(4), 921–923.PubMedGoogle Scholar
  32. 32.
    Santaguida, P. L., et al. (2014). BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: A systematic review. Heart Failure Reviews, 19(4), 453–470.PubMedCrossRefGoogle Scholar
  33. 33.
    McLean, A. S., & Huang, S. J. (2014). Brain not processing: is finding a role for BNP in sepsis like fitting a square peg into a round hole? Critical Care, 18(4), 161.PubMedCrossRefGoogle Scholar
  34. 34.
    Li, N., et al. (2013). BNP and NT-proBNP levels in patients with sepsis. Frontiers in Bioscience (Landmark Edition), 18, 1237–1243.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Hongxu Zu
    • 1
  • Qinghua Li
    • 1
  • Peixin Huang
    • 1
  • Xiaorong Wang
    • 1
    Email author
  1. 1.Department of BurnThe First Affiliated Hospital of Henan University of Science and TechnologyLuoyangChina

Personalised recommendations